SPY363.22+5.76 1.61%
DIA300.43+4.54 1.53%
IXIC12,036.79+156.15 1.31%

Cue Biopharma PR Shows Q3 EPS $(0.34) Down From $(0.31) YoY, Sales $704.00K Down From $984.00K YoY; Results Were Out Last Week In A Filing

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.34) per share. This is a 9.68 percent decrease over losses of $(0.31) per share from the same period last year. The company reported $704.00 thousand in sales

· 11/17/2020 16:03
Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.34) per share. This is a 9.68 percent decrease over losses of $(0.31) per share from the same period last year. The company reported $704.00 thousand in sales this quarter. This is a 28.46 percent decrease over sales of $984.00 thousand the same period last year.